![YG7 YG7](https://data.pdbj.org/pdbjplus/data/cc/svg/YG7.svg) | YG7 | Name: | 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide | Formula: | C26 H27 N5 O2 | SMILES: | N#Cc1ccc2[NH]cc(CCCCN3CCN(CC3)c3cc4cc(oc4cc3)C(N)=O)c2c1 | InChi: | InChI=1S/C26H27N5O2/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32) | Definition date: | 2021-03-02 | Last modified: | 2021-08-06 | Release date: | 2021-08-11 | Identifier: | 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide |
|
![YQV YQV](https://data.pdbj.org/pdbjplus/data/cc/svg/YQV.svg) | YQV | Name: | methyl {(1S,2R)-2-[(1S)-2-(azetidin-1-yl)-1-(3-fluorophenyl)-1-{1-[(3-methoxy-1-{4-[(1S,4S)-5-propanoyl-2,5-diazabicyclo[2.2.1]heptane-2-sulfonyl]phenyl}azetidin-3-yl)methyl]piperidin-4-yl}ethyl]cyclopentyl}carbamate | Formula: | C42 H59 F N6 O6 S | SMILES: | O=S(=O)(c1ccc(cc1)N1CC(CN2CCC(CC2)C(CN2CCC2)(c2cccc(F)c2)C2CCCC2NC(=O)OC)(OC)C1)N1CC2CC1CN2C(=O)CC | InChi: | InChI=1S/C42H59FN6O6S/c1-4-39(50)48-24-35-23-34(48)25-49(35)56(52,53)36-14-12-33(13-15-36)47-27-41(28-47,55-3)26-46-20-16-30(17-21-46)42(29-45-18-7-19-45,31-8-5-9-32(43)22-31)37-10-6-11-38(37)44-40(51)54-2/h5,8-9,12-15,22,30,34-35,37-38H,4,6-7,10-11,16-21,23-29H2,1-3H3,(H,44,51)/t34-,35-,37-,38-,42-/m0/s1 | Definition date: | 2021-03-24 | Last modified: | 2021-08-06 | Release date: | 2021-08-11 | Identifier: | methyl {(1S,2R)-2-[(1S)-2-(azetidin-1-yl)-1-(3-fluorophenyl)-1-{1-[(3-methoxy-1-{4-[(1S,4S)-5-propanoyl-2,5-diazabicyclo[2.2.1]heptane-2-sulfonyl]phenyl}azetidin-3-yl)methyl]piperidin-4-yl}ethyl]cyclopentyl}carbamate |
|
![HUU HUU](https://data.pdbj.org/pdbjplus/data/cc/svg/HUU.svg) | HUU | Name: | 6-chloranyl-2-ethyl-N-[[4-[4-[4-(trifluoromethyloxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide | Formula: | C29 H28 Cl F3 N4 O2 | SMILES: | CCc1nc2ccc(Cl)cn2c1C(=O)NCc3ccc(cc3)N4CCC(CC4)c5ccc(OC(F)(F)F)cc5 | InChi: | InChI=1S/C29H28ClF3N4O2/c1-2-25-27(37-18-22(30)7-12-26(37)35-25)28(38)34-17-19-3-8-23(9-4-19)36-15-13-21(14-16-36)20-5-10-24(11-6-20)39-29(31,32)33/h3-12,18,21H,2,13-17H2,1H3,(H,34,38) | Synonyms: | Telacebec | Definition date: | 2021-02-04 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 6-chloranyl-2-ethyl-~{N}-[[4-[4-[4-(trifluoromethyloxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide |
|
![G70 G70](https://data.pdbj.org/pdbjplus/data/cc/svg/G70.svg) | G70 | Name: | (2~{S},4~{S})-4-[[2-[(1~{R},3~{R})-1-acetyloxy-4-methyl-3-[[(2~{S},3~{S})-3-methyl-2-[[(2~{R})-1-methylpiperidin-2-yl]carbonylamino]pentanoyl]amino]pentyl]-1,3-thiazol-4-yl]carbonylamino]-5-cyclohexyl-2-methyl-pentanoic acid | Formula: | C37 H61 N5 O7 S | SMILES: | CC[CH](C)[CH](NC(=O)[CH]1CCCCN1C)C(=O)N[CH](C[CH](OC(C)=O)c2scc(n2)C(=O)N[CH](CC3CCCCC3)C[CH](C)C(O)=O)C(C)C | InChi: | InChI=1S/C37H61N5O7S/c1-8-23(4)32(41-34(45)30-16-12-13-17-42(30)7)35(46)39-28(22(2)3)20-31(49-25(6)43)36-40-29(21-50-36)33(44)38-27(18-24(5)37(47)48)19-26-14-10-9-11-15-26/h21-24,26-28,30-32H,8-20H2,1-7H3,(H,38,44)(H,39,46)(H,41,45)(H,47,48)/t23-,24-,27+,28+,30+,31+,32-/m0/s1 | Definition date: | 2020-08-04 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | (2~{S},4~{S})-4-[[2-[(1~{R},3~{R})-1-acetyloxy-4-methyl-3-[[(2~{S},3~{S})-3-methyl-2-[[(2~{R})-1-methylpiperidin-2-yl]carbonylamino]pentanoyl]amino]pentyl]-1,3-thiazol-4-yl]carbonylamino]-5-cyclohexyl-2-methyl-pentanoic acid |
|
![J00 J00](https://data.pdbj.org/pdbjplus/data/cc/svg/J00.svg) | J00 | Name: | 2-[(3S)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]prop-2-enoic acid | Formula: | C10 H9 B O4 | SMILES: | OB1O[CH](C(=C)C(O)=O)c2ccccc12 | InChi: | InChI=1S/C10H9BO4/c1-6(10(12)13)9-7-4-2-3-5-8(7)11(14)15-9/h2-5,9,14H,1H2,(H,12,13)/t9-/m1/s1 | Synonyms: | (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acrylic acid | Definition date: | 2021-03-08 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 2-[(3~{S})-1-oxidanyl-3~{H}-2,1-benzoxaborol-3-yl]prop-2-enoic acid |
|
![J0F J0F](https://data.pdbj.org/pdbjplus/data/cc/svg/J0F.svg) | J0F | Name: | 5-bromanyl-2-methyl-6-propyl-7H-pyrrolo[2,3-d]pyrimidine | Formula: | C10 H12 Br N3 | SMILES: | CCCc1[nH]c2nc(C)ncc2c1Br | InChi: | InChI=1S/C10H12BrN3/c1-3-4-8-9(11)7-5-12-6(2)13-10(7)14-8/h5H,3-4H2,1-2H3,(H,12,13,14) | Definition date: | 2021-03-10 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 5-bromanyl-2-methyl-6-propyl-7~{H}-pyrrolo[2,3-d]pyrimidine |
|
![J0L J0L](https://data.pdbj.org/pdbjplus/data/cc/svg/J0L.svg) | J0L | Name: | 3,3-dimethyl-7-(methylamino)-1H-indol-2-one | Formula: | C11 H14 N2 O | SMILES: | CNc1cccc2c1NC(=O)C2(C)C | InChi: | InChI=1S/C11H14N2O/c1-11(2)7-5-4-6-8(12-3)9(7)13-10(11)14/h4-6,12H,1-3H3,(H,13,14) | Definition date: | 2021-03-10 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 3,3-dimethyl-7-(methylamino)-1~{H}-indol-2-one |
|
![GDF GDF](https://data.pdbj.org/pdbjplus/data/cc/svg/GDF.svg) | GDF | Name: | Vinorelbine | Formula: | C45 H54 N4 O8 | SMILES: | CCC1=C[CH]2C[N](C1)Cc3c([nH]c4ccccc34)[C](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[CH]7[C](O)([CH](OC(C)=O)[C]8(CC)C=CCN9CC[C]67[CH]89)C(=O)OC | InChi: | InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38-,39+,42+,43+,44-,45-/m0/s1 | Definition date: | 2020-08-19 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 |
|
![QPZ QPZ](https://data.pdbj.org/pdbjplus/data/cc/svg/QPZ.svg) | QPZ | Name: | 1,4-dimethyl-2-oxidanylidene-~{N}-(phenylmethyl)quinoline-6-sulfonamide | Formula: | C18 H18 N2 O3 S | SMILES: | CN1C(=O)C=C(C)c2cc(ccc12)[S](=O)(=O)NCc3ccccc3 | InChi: | InChI=1S/C18H18N2O3S/c1-13-10-18(21)20(2)17-9-8-15(11-16(13)17)24(22,23)19-12-14-6-4-3-5-7-14/h3-11,19H,12H2,1-2H3 | Definition date: | 2020-07-22 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 1,4-dimethyl-2-oxidanylidene-~{N}-(phenylmethyl)quinoline-6-sulfonamide |
|
![QRB QRB](https://data.pdbj.org/pdbjplus/data/cc/svg/QRB.svg) | QRB | Name: | 1-[[4-(oxidanylcarbamoyl)phenyl]methyl]-3,4-dihydro-2~{H}-quinoline-6-carboxamide | Formula: | C18 H19 N3 O3 | SMILES: | NC(=O)c1ccc2N(CCCc2c1)Cc3ccc(cc3)C(=O)NO | InChi: | InChI=1S/C18H19N3O3/c19-17(22)15-7-8-16-14(10-15)2-1-9-21(16)11-12-3-5-13(6-4-12)18(23)20-24/h3-8,10,24H,1-2,9,11H2,(H2,19,22)(H,20,23) | Definition date: | 2020-07-29 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 1-[[4-(oxidanylcarbamoyl)phenyl]methyl]-3,4-dihydro-2~{H}-quinoline-6-carboxamide |
|
![6ID 6ID](https://data.pdbj.org/pdbjplus/data/cc/svg/6ID.svg) | 6ID | Name: | ~{N}-[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-azanyl-5-[[$l^{1}-azanyl($l^{2}-azanylidene)methyl]-$l^{2}-azanyl]-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]-9-oxidanylidene-9-[4-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)piperazin-1-yl]nonanamide | Formula: | C61 H112 N34 O9 | SMILES: | NC(=N)NCCC[CH](NC(=O)[CH](CCCNC(N)=N)NC(=O)[CH](CCCNC(N)=N)NC(=O)[CH](CCCNC(N)=N)NC(=O)[CH](CCCNC(N)=N)NC(=O)[CH](CCCNC(N)=N)NC(=O)[CH](CCCNC(N)=N)NC(=O)CCCCCCCC(=O)N1CCN(CC1)c2ncnc3[nH]ccc23)C(N)=O | InChi: | InChI=1S/C61H112N34O9/c62-46(98)37(13-6-23-78-55(63)64)88-50(100)39(15-8-25-80-57(67)68)90-52(102)41(17-10-27-82-59(71)72)92-54(104)43(19-12-29-84-61(75)76)93-53(103)42(18-11-28-83-60(73)74)91-51(101)40(16-9-26-81-58(69)70)89-49(99)38(14-7-24-79-56(65)66)87-44(96)20-4-2-1-3-5-21-45(97)94-31-33-95(34-32-94)48-36-22-30-77-47(36)85-35-86-48/h22,30,35,37-43H,1-21,23-29,31-34H2,(H2,62,98)(H,87,96)(H,88,100)(H,89,99)(H,90,102)(H,91,101)(H,92,104)(H,93,103)(H4,63,64,78)(H4,65,66,79)(H4,67,68,80)(H4,69,70,81)(H4,71,72,82)(H4,73,74,83)(H4,75,76,84)(H,77,85,86)/t37-,38-,39-,40-,41-,42-,43-/m1/s1 | Definition date: | 2021-07-27 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | ~{N}-[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-[[(2~{R})-1-azanyl-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]-9-oxidanylidene-9-[4-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)piperazin-1-yl]nonanamide |
|
![LMO LMO](https://data.pdbj.org/pdbjplus/data/cc/svg/LMO.svg) | LMO | Name: | dodecyl 6-O-alpha-D-galactopyranosyl-beta-D-glucopyranoside | Formula: | C24 H46 O11 | SMILES: | C(OC1C(C(C(C(CO)O1)O)O)O)C2C(C(O)C(C(O2)OCCCCCCCCCCCC)O)O | InChi: | InChI=1S/C24H46O11/c1-2-3-4-5-6-7-8-9-10-11-12-32-23-21(30)20(29)18(27)16(35-23)14-33-24-22(31)19(28)17(26)15(13-25)34-24/h15-31H,2-14H2,1H3/t15-,16-,17+,18-,19+,20+,21-,22-,23-,24+/m1/s1 | Synonyms: | DDMB | Definition date: | 2020-12-21 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | dodecyl 6-O-alpha-D-galactopyranosyl-beta-D-glucopyranoside |
|
![H6U H6U](https://data.pdbj.org/pdbjplus/data/cc/svg/H6U.svg) | H6U | Name: | 2-(2-azanyl-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-oxidanyl-2-phenyl-ethyl]amino]ethyl]phenyl]ethanamide | Formula: | C21 H24 N4 O2 S | SMILES: | Nc1scc(CC(=O)Nc2ccc(CCNC[CH](O)c3ccccc3)cc2)n1 | InChi: | InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1 | Definition date: | 2020-11-20 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 2-(2-azanyl-1,3-thiazol-4-yl)-~{N}-[4-[2-[[(2~{R})-2-oxidanyl-2-phenyl-ethyl]amino]ethyl]phenyl]ethanamide |
|
![SJT SJT](https://data.pdbj.org/pdbjplus/data/cc/svg/SJT.svg) | SJT | Name: | spliceostatin A (form II) | Formula: | C28 H45 N O8 | SMILES: | CO[C]1(C)C[C](C)(O)[CH](O)[CH](O1)C=CC(C)=CC[CH]2O[CH](C)[CH](C[CH]2C)NC(=O)C=C[CH](C)OC(C)=O | InChi: | InChI=1S/C28H45NO8/c1-17(10-13-24-26(32)27(6,33)16-28(7,34-8)37-24)9-12-23-18(2)15-22(20(4)36-23)29-25(31)14-11-19(3)35-21(5)30/h9-11,13-14,18-20,22-24,26,32-33H,12,15-16H2,1-8H3,(H,29,31)/b13-10+,14-11-,17-9+/t18-,19-,20+,22+,23-,24+,26+,27-,28-/m0/s1 | Synonyms: | [(~{Z},2~{S})-5-[[(2~{R},3~{R},5~{S},6~{S})-6-[(2~{E},4~{E})-5-[(2~{R},3~{R},4~{S},6~{S})-6-methoxy-4,6-dimethyl-3,4-bis(oxidanyl)oxan-2-yl]-3-methyl-penta-2,4-dienyl]-2,5-dimethyl-oxan-3-yl]amino]-5-oxidanylidene-pent-3-en-2-yl] ethanoate | Definition date: | 2020-11-20 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | [(~{Z},2~{S})-5-[[(2~{R},3~{R},5~{S},6~{S})-6-[(2~{E},4~{E})-5-[(2~{R},3~{R},4~{S},6~{S})-6-methoxy-4,6-dimethyl-3,4-bis(oxidanyl)oxan-2-yl]-3-methyl-penta-2,4-dienyl]-2,5-dimethyl-oxan-3-yl]amino]-5-oxidanylidene-pent-3-en-2-yl] ethanoate |
|
![RW8 RW8](https://data.pdbj.org/pdbjplus/data/cc/svg/RW8.svg) | RW8 | Name: | methyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate | Formula: | C13 H15 N O3 | SMILES: | COC(=O)CCC(=O)N1CCc2ccccc12 | InChi: | InChI=1S/C13H15NO3/c1-17-13(16)7-6-12(15)14-9-8-10-4-2-3-5-11(10)14/h2-5H,6-9H2,1H3 | Definition date: | 2020-10-27 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | methyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate |
|
![RXE RXE](https://data.pdbj.org/pdbjplus/data/cc/svg/RXE.svg) | RXE | Name: | ~{N}'-[2-(3,4-dichlorophenyl)ethyl]-~{N}-[4-[4,5,6,7-tetrakis(bromanyl)benzimidazol-1-yl]butyl]butanediamide | Formula: | C23 H22 Br4 Cl2 N4 O2 | SMILES: | Clc1ccc(CCNC(=O)CCC(=O)NCCCCn2cnc3c(Br)c(Br)c(Br)c(Br)c23)cc1Cl | InChi: | InChI=1S/C23H22Br4Cl2N4O2/c24-18-19(25)21(27)23-22(20(18)26)32-12-33(23)10-2-1-8-30-16(34)5-6-17(35)31-9-7-13-3-4-14(28)15(29)11-13/h3-4,11-12H,1-2,5-10H2,(H,30,34)(H,31,35) | Synonyms: | KN2 | Definition date: | 2020-10-29 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | ~{N}'-[2-(3,4-dichlorophenyl)ethyl]-~{N}-[4-[4,5,6,7-tetrakis(bromanyl)benzimidazol-1-yl]butyl]butanediamide |
|
![TK9 TK9](https://data.pdbj.org/pdbjplus/data/cc/svg/TK9.svg) | TK9 | Name: | (2~{R})-2-[[4-[[4-methoxy-2-(trifluoromethyl)phenyl]methylcarbamoyl]phenyl]methyl]butanoic acid | Formula: | C21 H22 F3 N O4 | SMILES: | CC[CH](Cc1ccc(cc1)C(=O)NCc2ccc(OC)cc2C(F)(F)F)C(O)=O | InChi: | InChI=1S/C21H22F3NO4/c1-3-14(20(27)28)10-13-4-6-15(7-5-13)19(26)25-12-16-8-9-17(29-2)11-18(16)21(22,23)24/h4-9,11,14H,3,10,12H2,1-2H3,(H,25,26)(H,27,28)/t14-/m1/s1 | Definition date: | 2020-09-01 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | (2~{R})-2-[[4-[[4-methoxy-2-(trifluoromethyl)phenyl]methylcarbamoyl]phenyl]methyl]butanoic acid |
|
![TQG TQG](https://data.pdbj.org/pdbjplus/data/cc/svg/TQG.svg) | TQG | Name: | N-[(3-carboxyphenoxy)acetyl]-L-glutamic acid | Formula: | C14 H15 N O8 | SMILES: | O=C(O)CCC(C(O)=O)NC(COc1cccc(c1)C(O)=O)=O | InChi: | InChI=1S/C14H15NO8/c16-11(15-10(14(21)22)4-5-12(17)18)7-23-9-3-1-2-8(6-9)13(19)20/h1-3,6,10H,4-5,7H2,(H,15,16)(H,17,18)(H,19,20)(H,21,22)/t10-/m0/s1 | Definition date: | 2020-03-26 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | N-[(3-carboxyphenoxy)acetyl]-L-glutamic acid |
|
![SQW SQW](https://data.pdbj.org/pdbjplus/data/cc/svg/SQW.svg) | SQW | Name: | propan-2-yl 4-indol-1-yl-4-oxidanylidene-butanoate | Formula: | C15 H17 N O3 | SMILES: | CC(C)OC(=O)CCC(=O)n1ccc2ccccc12 | InChi: | InChI=1S/C15H17NO3/c1-11(2)19-15(18)8-7-14(17)16-10-9-12-5-3-4-6-13(12)16/h3-6,9-11H,7-8H2,1-2H3 | Definition date: | 2020-11-30 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | propan-2-yl 4-indol-1-yl-4-oxidanylidene-butanoate |
|
![SRH SRH](https://data.pdbj.org/pdbjplus/data/cc/svg/SRH.svg) | SRH | Name: | ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate | Formula: | C14 H17 N O3 | SMILES: | CCOC(=O)CCC(=O)N1CCc2ccccc12 | InChi: | InChI=1S/C14H17NO3/c1-2-18-14(17)8-7-13(16)15-10-9-11-5-3-4-6-12(11)15/h3-6H,2,7-10H2,1H3 | Definition date: | 2020-11-30 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate |
|
![SRK SRK](https://data.pdbj.org/pdbjplus/data/cc/svg/SRK.svg) | SRK | Name: | 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoic acid | Formula: | C12 H13 N O3 | SMILES: | OC(=O)CCC(=O)N1CCc2ccccc12 | InChi: | InChI=1S/C12H13NO3/c14-11(5-6-12(15)16)13-8-7-9-3-1-2-4-10(9)13/h1-4H,5-8H2,(H,15,16) | Definition date: | 2020-11-30 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoic acid |
|
![SRQ SRQ](https://data.pdbj.org/pdbjplus/data/cc/svg/SRQ.svg) | SRQ | Name: | 2,2-bis(fluoranyl)ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate | Formula: | C14 H15 F2 N O3 | SMILES: | FC(F)COC(=O)CCC(=O)N1CCc2ccccc12 | InChi: | InChI=1S/C14H15F2NO3/c15-12(16)9-20-14(19)6-5-13(18)17-8-7-10-3-1-2-4-11(10)17/h1-4,12H,5-9H2 | Definition date: | 2020-11-30 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 2,2-bis(fluoranyl)ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate |
|
![UTB UTB](https://data.pdbj.org/pdbjplus/data/cc/svg/UTB.svg) | UTB | Name: | 1-[(2~{R},4~{S},5~{R})-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]-5-(2-pyren-1-ylethynyl)pyrimidine-2,4-dione | Formula: | C27 H20 N2 O5 | SMILES: | OC[CH]1O[CH](C[CH]1O)N2C=C(C#Cc3ccc4ccc5cccc6ccc3c4c56)C(=O)NC2=O | InChi: | InChI=1S/C27H20N2O5/c30-14-22-21(31)12-23(34-22)29-13-19(26(32)28-27(29)33)9-5-15-4-6-18-8-7-16-2-1-3-17-10-11-20(15)25(18)24(16)17/h1-4,6-8,10-11,13,21-23,30-31H,12,14H2,(H,28,32,33)/t21-,22+,23+/m0/s1 | Definition date: | 2021-03-17 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 1-[(2~{R},4~{S},5~{R})-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]-5-(2-pyren-1-ylethynyl)pyrimidine-2,4-dione |
|
![V07 V07](https://data.pdbj.org/pdbjplus/data/cc/svg/V07.svg) | V07 | Name: | 7-(azepan-1-yl)-3-(4-fluorophenyl)-5-methylpyrazolo[1,5-a]pyrimidine | Formula: | C19 H21 F N4 | SMILES: | c3(n1c(c(cn1)c2ccc(cc2)F)nc(C)c3)N4CCCCCC4 | InChi: | InChI=1S/C19H21FN4/c1-14-12-18(23-10-4-2-3-5-11-23)24-19(22-14)17(13-21-24)15-6-8-16(20)9-7-15/h6-9,12-13H,2-5,10-11H2,1H3 | Synonyms: | MAC-0547630 | Definition date: | 2020-06-09 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 7-(azepan-1-yl)-3-(4-fluorophenyl)-5-methylpyrazolo[1,5-a]pyrimidine |
|
![V0D V0D](https://data.pdbj.org/pdbjplus/data/cc/svg/V0D.svg) | V0D | Name: | 7-(azepan-1-yl)-5-ethyl-3-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine | Formula: | C20 H23 F N4 | SMILES: | C1N(CCCCC1)c4n2c(c(cn2)c3ccc(cc3)F)nc(c4)CC | InChi: | InChI=1S/C20H23FN4/c1-2-17-13-19(24-11-5-3-4-6-12-24)25-20(23-17)18(14-22-25)15-7-9-16(21)10-8-15/h7-10,13-14H,2-6,11-12H2,1H3 | Definition date: | 2020-06-09 | Last modified: | 2021-07-30 | Release date: | 2021-08-04 | Identifier: | 7-(azepan-1-yl)-5-ethyl-3-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine |
|